There’s just nothing to stop it, and it’s going to be a lot of fun.” Martha highlighted Medtronic’s Evolut FX+ transcatheter aortic valve replacement (TAVR) system as a key innovation in the ...

Barclays said clinicians have demonstrated a strong preference for BEV TAVR (balloon-expandable transcatheter aortic valve replacement). "AVR’s DurAVR valve system is on track to be the second ...

Barclays said clinicians have demonstrated a strong preference for BEV TAVR (balloon-expandable transcatheter aortic valve replacement), which are self-expanding. "AVR’s DurAVR valve system is ...

Barclays said clinicians have demonstrated a strong preference for BEV TAVR (balloon-expandable transcatheter aortic valve replacement). “AVR’s DurAVR valve system is on track to be the second balloon ...

The firm's analysis highlighted the potential market impact of Anteris's DurAVR valve system, which is anticipated to become the second balloon-expandable transcatheter aortic valve replacement (TAVR) ...

Anteris Technologies' DurAVR system expected to capture 4%-5% of the U.S. TAVR market by 2030, driven by strong clinician preference for BEV Analyst forecasts DurAVR's superior hemodynamics ...